Novo Nordisk is facing a massive wave of generic competitors to its injectable formulations of GLP-1 agonist semaglutide, used to treat diabetes and obesity, as a key patent in India is due to expire ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

https://www.thehindubusinessline.com/companies/natco-pharma-launches-generic-semaglutide-injection-in-india/article70764288.ece Copy Natco Pharma has launched the ...

BuyCanadianInsulin.com reports that generic semaglutide may become available in Canada in 2026 following changes in regulatory protections associated with the medication. The development reflects a ...

Background: Beginning in 2015, several groups of prescription drug buyers brought class-action lawsuits against Ranbaxy, accusing the pharmaceutical company of fraudulently obstructing the U.S. Food ...

The Democratic Party has a deeply motivated base and a clear advantage on the generic congressional ballot ahead of this fall’s midterms despite dismal impressions of its current leaders in Congress, ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

SALT LAKE CITY — The Utah Department of Commerce's Division of Consumer Protection and the Utah Attorney General's Office have reached a settlement with global pharmaceutical company Sandoz Inc. in a ...

Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ...